Search Videos and More


Study of Fully Vaccinated Patients with Cancer who had Breakthrough COVID-19 Shows 13% Mortality Rate News

Study of Fully Vaccinated Patients with Cancer who had Breakthrough COVID-19 Shows 13% Mortality Rate

The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
COVID-19 and Cancer: Breakthrough Infections Video

COVID-19 and Cancer: Breakthrough Infections

New study: Fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Dana-Farber's Toni Choueiri, MD, highlights the research.
COVID-19 vaccine and blood cancer Video

COVID-19 vaccine and blood cancer

Dr. Nikhil Munshi and colleagues reported a study demonstrating that COVID-19 vaccination offers less protection for multiple myeloma patients, reinforcing the need for these patients to use additional precautions.
Episode 6: Dana-Farber in the Time of COVID Podcast

Episode 6: Dana-Farber in the Time of COVID

A beauty… that in some cases becomes tragic. It's not the way most people would describe a virus. In the simplest of terms, a virus is a snippet of genetic code. It can't reproduce on its own. In order to replicate, it needs to infect and hijack a living cell.
Newsweek Names Dana-Farber #3 in the World for Cancer News

Newsweek Names Dana-Farber #3 in the World for Cancer

Dana-Farber Cancer Institute has been named one of the world’s very best cancer hospitals by Newsweek in its new World’s Best Specialized Hospitals 2022 rankings.
COVID-19 Vaccine Study in Cancer Patients Video

COVID-19 Vaccine Study in Cancer Patients

Dana-Farber researchers are leading a study that looks at the effects of the COVID-19 vaccine in cancer patients.
Study Underscores Need for Multidisciplinary Care for COVID-19 Long-Haulers News

Study Underscores Need for Multidisciplinary Care for COVID-19 Long-Haulers

Physicians across the country have analyzed the emerging scientific data about the long-term effects of COVID-19, creating an initial knowledge base about the clinical experiences of so-called “long-haulers” – patients with COVID-19 who experience prolonged symptoms and/or the emergence of new ones well after the initial viral infection has resolved. A comprehensive review published today in Nature Medicine offers an initial glimpse of the multi-organ effects of long-term COVID-19 and suggests a framework for the care of COVID-19 long-haulers through dedicated, multidisciplinary clinics.
Study Shows Sharp Decline in Cancer Screenings and Diagnoses During the First Covid-19 Surge News

Study Shows Sharp Decline in Cancer Screenings and Diagnoses During the First Covid-19 Surge

In one of the first studies to examine the impact of the COVID-19 pandemic on cancer diagnoses, researchers at Dana-Farber/Brigham and Women’s Cancer Center document a substantial decline in cancer and precancer diagnoses at the Northeast’s largest health care system during the first peak of the pandemic because of a drop in the number of cancer screening tests performed.
Communicating With Families of Seriously Ill Patients with COVID-19: What are The Guidelines? Which Models Can Help You Manage These Difficult Conversations? Video

Communicating With Families of Seriously Ill Patients with COVID-19: What are The Guidelines? Which Models Can Help You Manage These Difficult Conversations?

Richard Leiter, MD, MA, presents on patients with Covid-19 and how to communicate with their families and how to have difficult conversations.